한글목차

강압제의 동향과 예측

세계의 강압제 시장은 2024-2030년 CAGR 4.7%의 성장이 전망됩니다. 이 시장의 주요 촉진요인은 고혈압의 이환율 증가, 민간 및 정부기관에 의한 노력 및 구상의 증가, 고혈압에 대한 의식의 향상입니다. 세계의 강압제 시장의 미래는 소매 약국, 병원 약국, E-Commerce 시장에 비즈니스 기회가 있으며, 유망시되고 있습니다.

강압제 시장 인사이트

Lucintel의 예측에서 칼슘 길항제는 기타 치료제와 비교하여 가격이 적당하고, 유효성이 높고, 부작용이 적으므로 예측 기간 중에도 최대 부문을 유지할 것으로 예상됩니다.

이 시장에서는 세계의 병원 수의 증가에 의해 병원이 계속해서 최대 부문을 유지합니다.

북미는 고혈압의 이환율 급증과 노년 인구의 증가에 의해 예측 기간 중에도 최대 지역을 유지할 것으로 생각됩니다.

아래 11개의 주요 질문에 답변하고 있습니다 :

• Q.1.시장 부문 중 가장 유망하고 고성장인 기회는 무엇인가?
• Q.2.어느 부문이 보다 빠른 페이스로 성장하는가, 또 이유는?
• Q.3.어느 지역이 보다 빠른 페이스로 성장한다고 생각합니까?
• Q.4.시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장에서 주요 과제와 비즈니스 리스크는?
• Q.5.시장에서 비즈니스 리스크와 경쟁의 위협은?
• Q.6.이 시장에서 새로운 동향과 이유는?
• Q.7.시장에서 고객의 수요 변화에는 어떤 것이 있는가?
• Q.8.이 시장에서 새로운 개발과 개발을 선도하고 있는 기업은?
• Q.9.이 시장의 주요 기업은? 주요 기업은 사업 성장을 위해 어떤 전략적 구상을 진행시키고 있는가?
• Q.10.이 시장에서의 경쟁 제품은 무엇이며, 재료 및 제품의 대체에 의한 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11.과거 5년간 어떤 M&A가 시행되고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 강압제 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018-2030년의 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 강압제 시장 동향(2018-2023년)과 예측(2024-2030년)
• 치료제 클래스별 세계의 강압제 시장
  • 이뇨제
  • ACE 저해제
  • 칼슘 길항제
  • 혈관확장제
  • 베타 아드레날린 차단제
  • 기타
• 유통 채널별 세계의 강압제 시장
  • 소매 약국
  • 병원 약국
  • E-Commerce
  • 기타

제4장 2018-2030년의 지역별 시장 동향과 예측 분석

• 지역별 세계의 강압제 시장
• 북미의 강압제 시장
• 유럽의 강압제 시장
• 아시아태평양의 강압제 시장
• 기타 지역의 강압제 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 치료제 클래스별 세계의 강압제 시장의 성장 기회
  • 유통 채널별 세계의 강압제 시장의 성장 기회
  • 지역별 세계의 강압제 시장의 성장 기회
• 세계의 강압제 시장의 새로운 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 강압제 시장의 능력 확대
  • 세계의 강압제 시장에서의 합병, 인수, 합병사업
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• Lupin
• Boehringer Ingelheim International
• Sun PharmACEutical Industries
• AstraZeneca
• Novartis
• SANOFI
• Merck

영문목차

Antihypertensive Drug Trends and Forecast

The future of the global antihypertensive drug market looks promising with opportunities in the retail pharmacy, hospital pharmacy, and e-commerce markets. The global antihypertensive drug market is expected to grow with a CAGR of 4.7% from 2024 to 2030. The major drivers for this market are growing incidence of hypertension, rising efforts and initiatives by both private and government organizations, and increasing awareness of hypertension.

A more than 150-page report is developed to help in your business decisions.

Antihypertensive Drug by Segment

The study includes a forecast for the global antihypertensive drug by therapeutic class, distribution channel, and region.

Antihypertensive Drug Market by Therapeutic Class [Shipment Analysis by Value from 2018 to 2030]:

• Diuretics
• ACE Inhibitors
• Calcium Channel Blockers
• Vasodilators
• Beta-Adrenergic Blockers
• Others

Antihypertensive Drug Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Retail Pharmacy
• Hospital Pharmacy
• E-Commerce
• Others

Antihypertensive Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Antihypertensive Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies antihypertensive drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the antihypertensive drug companies profiled in this report include-

• Lupin
• Boehringer Ingelheim International
• Sun PharmACEutical Industries
• Astrazeneca
• Novartis
• SANOFI
• Merck

Antihypertensive Drug Market Insights

Lucintel forecasts that calcium channel blocker will remain the largest segment over the forecast period due to its affordability, high efficacy, and lesser side effects as compare to other therapeutic classes.

Within this market, hospital will remain the largest segment due to increase in number of hospitals worldwide.

North America will remain the largest region over the forecast period due to surge in incidence of hypertension and rise in geriatric population.

Features of the Global Antihypertensive Drug Market

Market Size Estimates: Antihypertensive drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Antihypertensive drug market size by therapeutic class, distribution channel, and region in terms of value ($B).

Regional Analysis: Antihypertensive drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapeutic classes, distribution channels, and regions for the antihypertensive drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the antihypertensive drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for antihypertensive drug market?

Answer: The global antihypertensive drug market is expected to grow with a CAGR of 4.7% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the antihypertensive drug market?

Answer: The major drivers for this market are growing incidence of hypertension, rising efforts and initiatives by both private and government organizations, and increasing awareness of hypertension.

Q3. What are the major segments for antihypertensive drug market?

Answer: The future of the antihypertensive drug market looks promising with opportunities in the retail pharmacy, hospital pharmacy, and e-commerce markets.

Q4. Who are the key antihypertensive drug market companies?

Answer: Some of the key antihypertensive drug companies are as follows:

• Lupin
• Boehringer Ingelheim International
• Sun PharmACEutical Industries
• Astrazeneca
• Novartis
• SANOFI
• Merck

Q5. Which antihypertensive drug market segment will be the largest in future?

Answer: Lucintel forecasts that calcium channel blocker will remain the largest segment over the forecast period due to its affordability, high efficacy, and lesser side effects as compare to other therapeutic classes.

Q6. In antihypertensive drug market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to surge in incidence of hypertension and rise in geriatric population.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the antihypertensive drug market by therapeutic class (diuretics, ACE inhibitors, calcium channel blockers, vasodilators, beta-adrenergic blockers, and others), distribution channel (retail pharmacy, hospital pharmacy, e-commerce, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pACE and why?
• Q.3. Which region will grow at a faster pACE and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Antihypertensive Drug Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Antihypertensive Drug Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Antihypertensive Drug Market by Therapeutic Class
  • 3.3.1: Diuretics
  • 3.3.2: ACE Inhibitors
  • 3.3.3: Calcium Channel Blockers
  • 3.3.4: Vasodilators
  • 3.3.5: Beta-adrenergic Blockers
  • 3.3.6: Others
• 3.4: Global Antihypertensive Drug Market by Distribution Channel
  • 3.4.1: Retail Pharmacy
  • 3.4.2: Hospital Pharmacy
  • 3.4.3: E-commerce
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Antihypertensive Drug Market by Region
• 4.2: North American Antihypertensive Drug Market
  • 4.2.2: North American Antihypertensive Drug Market by Distribution Channel: Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others
• 4.3: European Antihypertensive Drug Market
  • 4.3.1: European Antihypertensive Drug Market by Therapeutic Class: Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others
  • 4.3.2: European Antihypertensive Drug Market by Distribution Channel: Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others
• 4.4: APAC Antihypertensive Drug Market
  • 4.4.1: APAC Antihypertensive Drug Market by Therapeutic Class: Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others
  • 4.4.2: APAC Antihypertensive Drug Market by Distribution Channel: Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others
• 4.5: ROW Antihypertensive Drug Market
  • 4.5.1: ROW Antihypertensive Drug Market by Therapeutic Class: Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others
  • 4.5.2: ROW Antihypertensive Drug Market by Distribution Channel: Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Antihypertensive Drug Market by Therapeutic Class
  • 6.1.2: Growth Opportunities for the Global Antihypertensive Drug Market by Distribution Channel
  • 6.1.3: Growth Opportunities for the Global Antihypertensive Drug Market by Region
• 6.2: Emerging Trends in the Global Antihypertensive Drug Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Antihypertensive Drug Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Antihypertensive Drug Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Lupin
• 7.2: Boehringer Ingelheim International
• 7.3: Sun PharmACEutical Industries
• 7.4: AstraZeneca
• 7.5: Novartis
• 7.6: SANOFI
• 7.7: Merck